Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global infection control market was valued at US$ 215.34 billion in 2021 and is expected to register a revenue CAGR of 6.5% to reach US$ 379.55 billion by 2030.

Infection Control Market Fundamentals 

Microorganisms, such as viruses, bacteria, fungi, and parasites, are mostly responsible for infections, which can range from stomach and intestinal infections to lung and respiratory infections, eye and ear infections, hospital-acquired infections (HAIs), skin infections, and sexually transmitted infections. Cross-infection from the surface and skin of the patient, equipment, and healthcare staff can cause these illnesses. The expanding number of surgical procedures, the need to lower the risk of HIAs, and a growing emphasis on food sterilization are significant factors driving the infection control market. Both patients and healthcare providers are concerned about HAIs. According to estimates, 1.7 million HIAs occur each year, and about 100,000 of these cases result in death. Infection-causing bacteria, fungi, and viruses are frequently exposed to healthcare professionals.

Infections can develop during three common healthcare procedures: surgery, catheter insertion, and injections, as well as catheter-associated urinary tract infections and pneumonia induced by ventilators. Furthermore, the rising frequency of HAIs and infectious virus-related disorders is boosting demand for infection control strategies. Technological advancements and public awareness have contributed to an increase in surgical procedures, which has led to an increase in demand for infection control. Surgical site infections (SSI) in surgery patients account for 14% to 17% of all HIAs and 38% of all nosocomial infections. According to 2019 data, nearly 1.84 million procedures were performed in recognized hospitals in the United States.

Infections caused by germs or bacteria necessitate proper sanitation. Surgical tools and equipment must be sterilized and disinfected to decrease disease transmission; hence, infection control measures are required to reduce infection transmission among patients and hospital staff. Furthermore, infections associated with health care significantly burden patients, society, and health care administration. The advent of life-threatening infections, such as SARS, and re-emerging infectious diseases, such as plague and tuberculosis, have emphasized the need for effective infection control programs in all healthcare settings and capacity building for healthcare personnel. An infection control program is effective when it limits infection transmission among hospital patients and employees. A good infection control program also significantly reduces patients' morbidity and mortality, length of hospital stays, and hospital costs.

[6744564]

Infection Control Market Dynamics 

The major factors driving the global infection control market are an increase in the incidence of HIAs, rise in the number of surgical procedures that require high-intensity infection prevention and control, a growth in the number of government awareness programs to ensure a high degree of infection prevention, rising geriatric population, and chronic diseases such as diabetes, obesity, cancer, heart, and respiratory disorders. Furthermore, an increase in the need for sterilization and disinfection in hospitals and clinics, technological advancements in related equipment, outsourcing of sterilization services among hospitals, pharmaceutical and medical device companies, and growth in the production of medical nonwovens and single-use products due to the COVID-19 pandemic are expected to drive the revenue growth of the infection control market. Additionally, a rising number of comprehensive infection prevention and control training modules for nurses and other medical workers is expected to increase the potential for widespread use of infection control products in the next years. For instance, the College of Nurses of Ontario issued guidelines on standard procedures, focusing on maintaining hand cleanliness to avoid contamination and infection spread. Furthermore, the Centers for Disease Control and Prevention (CDC) issued disinfection and sterilization guidelines for the effective usage of infection control products by healthcare staff in various settings, including ambulatory care, home care, hospitals, and others.

Infection Control Market Ecosystem

The global infection control market has been analyzed from three perspectives: product, end user, and region.

Infection Control Market by Product
[85646334]

Based on product, the global infection control market has been segmented into sterilization, disinfection, endoscope reprocessing, and protective barriers.

The sterilization segment is sub-segmented into steam, radiation, sterilant, and indicators products. The disinfection segment is sub-segmented into washers, UV disinfection, and disinfectants. The sterilization segment is expected to dominate the market during the forecast period. Sterilization is essential for controlling infectious diseases that may exist throughout hospitals or healthcare facilities, and it is debatable whether antibiotics can manage such a widespread attack.

Infection Control Market by End User

Based on end user, the global infection control market has been segmented into hospitals & clinics, pharmaceutical & medical device companies, and others.

The hospitals & clinics segment dominates the market due to the high volume of surgical procedures performed in hospitals, greater incidence of HIAs, and rise in the number of hospitals and clinics. The increase in the geriatric population and chronic disease prevalence further supports segment revenue growth. Additionally, the segment expansion can be attributed to the rising demand for contagious disease management, such as COVID-19, and the subsequent need for disposable infection control supplies, such as face masks, gloves, surgical gowns, and personal protective equipment (PPEs).

Infection Control Market by Region 

Based on region, the global infection control market has been segmented into North America, Europe, Asia Pacific, Rest of the World.

North America is expected to dominate the market during the forecast period. The market revenue growth can be attributed to the high adoption of cleaning and sanitization solutions alongside administrations due to the rising emphasis on healthy living and sickness prevention among clients. The aging population and proportionate increase in chronic illness prevalence, the need for infection control to limit the spread of HAIs, and the implementation of positive government campaigns and stringent guidelines on sanitization and sterilization are driving the infection control market revenue growth in North America.

The infection control market is expected to grow at the fastest revenue CAGR in Asia Pacific during the forecast period, owing to the growing presence of rethinking associations, increasing medical services consumption, and remarkable medical care guidelines and foundation advancements across this sector. The presence of several government associations focused on further developing disease control regulations and guidelines is also one of the major factors contributing to the development of the Asia Pacific region. The expanding pattern of re-appropriation by established market participants in developed economies to organizations in the Asia Pacific region also serves as a significant development-stimulating factor for the industry.

Infection Control Market Competitive Landscape 

The prominent market players in the global infection control market include: 

• 3M Company
• Belimed AG
• Halyard Health, Inc.
• Getinge Group
• Cantel Medical Corporation
• Advanced Sterilization Products
• Matchana Group
• Reckitt Benckiser
• Sterigenics International
• MMM Group
• Honeywell International, Inc.
• Cantel Medical Corporation
• STERIS Corporation
• Ecolab

The global infection control market is competitive and moderately fragmented. Industry players focus on product launches, product developments, and regional expansion to increase their market revenue share.

Infection Control Market Strategic Developments 

• In September 2022, 3M Company declared the completion of both the split-off exchange offer for 3M common shares and the merger of Garden SpinCo Corporation ("SpinCo"), the 3M subsidiary owning the food safety business, with a subsidiary of Neogen Corporation ("Neogen"). SpinCo is currently owned entirely by Neogen
• In June 2022, Belimed AG acquired Amity International, a specialized chemical company in the United Kingdom. During the last three decades, Amity has developed a specialized assortment of chemicals, supplies, and machinery for the worldwide healthcare business.
• In November 2021, STERIS announced an agreement to acquire Cantel, a global supplier of contamination anticipation goods and administrations, through a U.S. subsidiary, to widen its vast assortment of disease control items and administrations
• In August 2021, Advanced Sterilization Products, a Fortive company, introduced the STERRAD VELOCITY, a biological Indicator (BI)/process challenge device (PCD)

Frequently Asked Questions About This Report